Literature DB >> 26888987

Longitudinal functional and NMR assessment of upper limbs in Duchenne muscular dystrophy.

Jean-Yves Hogrel1, Claire Wary2, Amélie Moraux2, Noura Azzabou2, Valérie Decostre2, Gwenn Ollivier2, Aurélie Canal2, Charlotte Lilien2, Isabelle Ledoux2, Mélanie Annoussamy2, Nacera Reguiba2, Teresa Gidaro2, Anne Gaelle Le Moing2, Ruxandra Cardas2, Thomas Voit2, Pierre G Carlier2, Laurent Servais2.   

Abstract

OBJECTIVE: To explore the value of nuclear magnetic resonance (NMR) and functional assessments for follow-up of ambulatory and nonambulatory patients with Duchenne muscular dystrophy (DMD).
METHODS: Twenty-five 53-skippable patients with DMD were included in this study; 15 were nonambulatory at baseline. All patients underwent clinical and functional assessments every 6 months using the Motor Function Measure (MFM), hand grip and key pinch strength, MoviPlate, and NMR spectroscopy and imaging studies.
RESULTS: Upper limb distal strength decreased in nonambulatory patients over the period of 1 year; ambulatory patients showed improvement during the same period. The same applied for several NMRS indices, such as phosphocreatine/adenosine triphosphate, which decreased in older patients but increased in younger ambulatory patients. Fat infiltration in the upper limbs increased linearly with age. Almost all NMR and functional assessment results correlated.
CONCLUSIONS: Our results underscore complementarity of functional and NMR assessments in patients with DMD. Sensitivity to change of various indices may differ according to disease stage.
© 2016 American Academy of Neurology.

Entities:  

Mesh:

Year:  2016        PMID: 26888987      PMCID: PMC4799716          DOI: 10.1212/WNL.0000000000002464

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

1.  Reliability and validity of active-seated: An outcome in dystrophinopathy.

Authors:  Linda P Lowes; Lindsay N Alfano; Roger Crawfis; Katherine Berry; Han Yin; Igor Dvorchik; Kevin M Flanigan; Jerry R Mendell
Journal:  Muscle Nerve       Date:  2015-07-02       Impact factor: 3.217

Review 2.  Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy.

Authors:  Anna Mayhew; Elena S Mazzone; Michelle Eagle; Tina Duong; Maria Ash; Valerie Decostre; Marlene Vandenhauwe; Katrijn Klingels; Julaine Florence; Marion Main; Flaviana Bianco; Erik Henrikson; Laurent Servais; Giles Campion; Elizabeth Vroom; Valeria Ricotti; Natalie Goemans; Craig McDonald; Eugenio Mercuri
Journal:  Dev Med Child Neurol       Date:  2013-08-01       Impact factor: 5.449

3.  Longitudinal Evaluation of Muscle Composition Using Magnetic Resonance in 4 Boys With Duchenne Muscular Dystrophy: Case Series.

Authors:  Claudia R Senesac; Donovan J Lott; Sean C Forbes; Sunita Mathur; Ishu Arpan; Emily S Senesac; Glenn A Walter; Krista Vandenborne
Journal:  Phys Ther       Date:  2015-01-15

4.  Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skipping.

Authors:  Adeline Vulin; Inès Barthélémy; Aurélie Goyenvalle; Jean-Laurent Thibaud; Cyriaque Beley; Graziella Griffith; Rachid Benchaouir; Maëva le Hir; Yves Unterfinger; Stéphanie Lorain; Patrick Dreyfus; Thomas Voit; Pierre Carlier; Stéphane Blot; Luis Garcia
Journal:  Mol Ther       Date:  2012-09-11       Impact factor: 11.454

5.  Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy.

Authors:  Claire Wary; Noura Azzabou; Céline Giraudeau; Julien Le Louër; Marie Montus; Thomas Voit; Laurent Servais; Pierre Carlier
Journal:  NMR Biomed       Date:  2015-07-27       Impact factor: 4.044

6.  Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression.

Authors:  R J Willcocks; I A Arpan; S C Forbes; D J Lott; C R Senesac; E Senesac; J Deol; W T Triplett; C Baligand; M J Daniels; H L Sweeney; G A Walter; K Vandenborne
Journal:  Neuromuscul Disord       Date:  2014-01-11       Impact factor: 4.296

7.  Nuclear magnetic resonance studies of forearm muscle in Duchenne dystrophy.

Authors:  R J Newman; P J Bore; L Chan; D G Gadian; P Styles; D Taylor; G K Radda
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-10

8.  Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy.

Authors:  Arne Fischmann; Patricia Hafner; Monika Gloor; Maurice Schmid; Andrea Klein; Urs Pohlman; Tanja Waltz; Rocio Gonzalez; Tanja Haas; Oliver Bieri; Dirk Fischer
Journal:  J Neurol       Date:  2012-11-09       Impact factor: 4.849

9.  Non-Ambulant Duchenne Patients Theoretically Treatable by Exon 53 Skipping have Severe Phenotype.

Authors:  Laurent Servais; Marie Montus; Caroline Le Guiner; Rabah Ben Yaou; Mélanie Annoussamy; Amélie Moraux; Jean-Yves Hogrel; Andreea M Seferian; Karima Zehrouni; Anne-Gaëlle Le Moing; Teresa Gidaro; Catherine Vanhulle; Vincent Laugel; Nina Butoianu; Jean-Marie Cuisset; Pascal Sabouraud; Claude Cances; Andrea Klein; France Leturcq; Philippe Moullier; Thomas Voit
Journal:  J Neuromuscul Dis       Date:  2015-09-02

10.  Stature is an essential predictor of muscle strength in children.

Authors:  Jean-Yves Hogrel; Valérie Decostre; Corinne Alberti; Aurélie Canal; Gwenn Ollivier; Emilie Josserand; Ilham Taouil; Dominique Simon
Journal:  BMC Musculoskelet Disord       Date:  2012-09-18       Impact factor: 2.362

View more
  24 in total

1.  Quantitative nuclear magnetic resonance imaging detects subclinical changes over 1 year in skeletal muscle of GNE myopathy.

Authors:  Teresa Gidaro; Harmen Reyngoudt; Julien Le Louër; Anthony Behin; Ferial Toumi; Melanie Villeret; Ericky C A Araujo; Pierre-Yves Baudin; Benjamin Marty; Melanie Annoussamy; Jean-Yves Hogrel; Pierre G Carlier; Laurent Servais
Journal:  J Neurol       Date:  2019-10-15       Impact factor: 4.849

Review 2.  Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials.

Authors:  Pierre G Carlier; Benjamin Marty; Olivier Scheidegger; Paulo Loureiro de Sousa; Pierre-Yves Baudin; Eduard Snezhko; Dmitry Vlodavets
Journal:  J Neuromuscul Dis       Date:  2016-03-03

3.  Quantitative Muscle MRI Protocol as Possible Biomarker in Becker Muscular Dystrophy.

Authors:  Lorenzo Maggi; Marco Moscatelli; Rita Frangiamore; Federica Mazzi; Mattia Verri; Alberto De Luca; Maria Barbara Pasanisi; Giovanni Baranello; Irene Tramacere; Luisa Chiapparini; Maria Grazia Bruzzone; Renato Mantegazza; Domenico Aquino
Journal:  Clin Neuroradiol       Date:  2020-01-23       Impact factor: 3.649

4.  Quantitative muscle ultrasound detects disease progression in Duchenne muscular dystrophy.

Authors:  Craig M Zaidman; Jim S Wu; Kush Kapur; Amy Pasternak; Lavanya Madabusi; Sung Yim; Adam Pacheck; Heather Szelag; Tim Harrington; Basil T Darras; Seward B Rutkove
Journal:  Ann Neurol       Date:  2017-05-04       Impact factor: 10.422

5.  Magnetic resonance imaging of the proximal upper extremity musculature in boys with Duchenne muscular dystrophy.

Authors:  R J Willcocks; W T Triplett; S C Forbes; H Arora; C R Senesac; D J Lott; T R Nicholson; W D Rooney; G A Walter; K Vandenborne
Journal:  J Neurol       Date:  2016-10-24       Impact factor: 4.849

6.  Eliminating Nox2 reactive oxygen species production protects dystrophic skeletal muscle from pathological calcium influx assessed in vivo by manganese-enhanced magnetic resonance imaging.

Authors:  James A Loehr; Gary R Stinnett; Mayra Hernández-Rivera; Wesley T Roten; Lon J Wilson; Robia G Pautler; George G Rodney
Journal:  J Physiol       Date:  2016-10-17       Impact factor: 5.182

7.  Relationship between markers of disease activity and progression in skeletal muscle of GNE myopathy patients using quantitative nuclear magnetic resonance imaging and 31P nuclear magnetic resonance spectroscopy.

Authors:  Harmen Reyngoudt; Benjamin Marty; Ericky Caldas de Almeida Araújo; Pierre-Yves Baudin; Julien Le Louër; Jean-Marc Boisserie; Anthony Béhin; Laurent Servais; Teresa Gidaro; Pierre G Carlier
Journal:  Quant Imaging Med Surg       Date:  2020-07

8.  Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort.

Authors:  Sean C Forbes; Harneet Arora; Rebecca J Willcocks; William T Triplett; William D Rooney; Alison M Barnard; Umar Alabasi; Dah-Jyuu Wang; Donovan J Lott; Claudia R Senesac; Ann T Harrington; Erika L Finanger; Gihan I Tennekoon; John Brandsema; Michael J Daniels; H Lee Sweeney; Glenn A Walter; Krista Vandenborne
Journal:  Radiology       Date:  2020-04-14       Impact factor: 11.105

9.  MR biomarkers predict clinical function in Duchenne muscular dystrophy.

Authors:  Alison M Barnard; Rebecca J Willcocks; William T Triplett; Sean C Forbes; Michael J Daniels; Saptarshi Chakraborty; Donovan J Lott; Claudia R Senesac; Erika L Finanger; Ann T Harrington; Gihan Tennekoon; Harneet Arora; Dah-Jyuu Wang; H Lee Sweeney; William D Rooney; Glenn A Walter; Krista Vandenborne
Journal:  Neurology       Date:  2020-02-05       Impact factor: 9.910

10.  Magnetic Resonance Imaging Studies in Duchenne Muscular Dystrophy: Linking Findings to the Physical Therapy Clinic.

Authors:  Claudia R Senesac; Alison M Barnard; Donovan J Lott; Kavya S Nair; Ann T Harrington; Rebecca J Willcocks; Kirsten L Zilke; William D Rooney; Glenn A Walter; Krista Vandenborne
Journal:  Phys Ther       Date:  2020-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.